Skip to main content
Top

Open Access 27-03-2024 | Neuroblastoma | Original Article

Potential Cause-and-Effect Relationship between Gut Microbiota and Childhood Neuroblastoma: A Mendelian Randomization Analysis

Author: Jing Chu

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

Objectives

To analyze the potential causal-effect of gut microbiota (GM) on neuroblastoma (NB) risk using a Mendelian randomization (MR) study.

Methods

A two-sample MR study was conducted using summary statistics of the GM from the largest available meta-analysis of genome-wide association studies conducted by the MiBioGen consortium. Pooled statistics for childhood NB were obtained from the IEU Consortium release data (1627 cases and 3254 controls). Inverse variance-weighted, weighted median, MR-Egger, and weighted mod were used to examine the causal relationship between GM and childhood NB. Single-nucleotide polymorphism (SNP) genes of positive GM were extracted using the PLINK program, and correlations between key SNP genes and tumor-regulated genes were analyzed. Functional enrichment analysis and transcription factor prediction were performed.

Results

Inverse variance weighted (IVW) results indicated that Erysipelotrichia exerted a protective effect against childhood NB (odds ratio = 0.371, 95% Confidence interval: 0.173 - 0.795, P = 0.011) and that Oscillospira exerted a risk effect against childhood NB (odds ratio = 2.378, 95% Confidence interval: 1.121 - 5.043, P = 0.024), indicating the association of GM with childhood NB. Further screening analysis using the IVW test revealed a reliable causal relationship between Erysipelotrichia and NB. Two SNP genes (MUC4 and PELI2) of Erysipelotrichia were extracted and analyzed. Both key genes were significantly associated with tumor-regulated genes, enriched in several pathways associated with tumor progression, and correlated with several upstream transcription factors.

Conclusions

It was observed that Erysipelotrichia is causally associated with NB using a two-sample MR study. Furthermore, the discovery of two SNP genes, MUC4 and PELI2, provides potential targets for the diagnosis and treatment of NB.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pudela C, Balyasny S, Applebaum MA. Nervous system: Embryonal tumors: Neuroblastoma. Atlas Genet Cytogenet Oncol Haematol. 2020;24:284–90.PubMedPubMedCentral Pudela C, Balyasny S, Applebaum MA. Nervous system: Embryonal tumors: Neuroblastoma. Atlas Genet Cytogenet Oncol Haematol. 2020;24:284–90.PubMedPubMedCentral
2.
go back to reference London WB, Castel V, Monclair T, et al. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. J Clin Oncol. 2011;29:3286–92.CrossRefPubMedPubMedCentral London WB, Castel V, Monclair T, et al. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. J Clin Oncol. 2011;29:3286–92.CrossRefPubMedPubMedCentral
3.
go back to reference Aravindan N, Herman T, Aravindan S. Emerging therapeutic targets for neuroblastoma. Expert Opin Ther Tar. 2020;24:899–914.CrossRef Aravindan N, Herman T, Aravindan S. Emerging therapeutic targets for neuroblastoma. Expert Opin Ther Tar. 2020;24:899–914.CrossRef
4.
go back to reference Teng NMY, Price CA, McKee AM, Hall LJ, Robinson SD. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. Int J Cancer. 2021;149:494–504.CrossRefPubMedPubMedCentral Teng NMY, Price CA, McKee AM, Hall LJ, Robinson SD. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. Int J Cancer. 2021;149:494–504.CrossRefPubMedPubMedCentral
5.
go back to reference Frankel TL, Pasca di Magliano M. Immune sensing of microbial metabolites: action at the tumor. Immunity. 2022;55:192–4.CrossRefPubMed Frankel TL, Pasca di Magliano M. Immune sensing of microbial metabolites: action at the tumor. Immunity. 2022;55:192–4.CrossRefPubMed
6.
go back to reference Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42:515–28.CrossRefPubMed Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42:515–28.CrossRefPubMed
7.
go back to reference Birney E. Mendelian randomization. Cold Spring Harb Perspect Med. 2022;12:a041302.PubMed Birney E. Mendelian randomization. Cold Spring Harb Perspect Med. 2022;12:a041302.PubMed
8.
9.
go back to reference Wei Z, Yang B, Tang T, et al. Gut microbiota and risk of five common cancers: a univariable and multivariable Mendelian randomization study. Cancer Med. 2023;12:10393–405.CrossRefPubMedPubMedCentral Wei Z, Yang B, Tang T, et al. Gut microbiota and risk of five common cancers: a univariable and multivariable Mendelian randomization study. Cancer Med. 2023;12:10393–405.CrossRefPubMedPubMedCentral
10.
go back to reference Tiffany CR, Lee JY, Rogers AWL, et al. The metabolic footprint of Clostridia and Erysipelotrichia reveals their role in depleting sugar alcohols in the cecum. Microbiome. 2021;9:174.CrossRefPubMedPubMedCentral Tiffany CR, Lee JY, Rogers AWL, et al. The metabolic footprint of Clostridia and Erysipelotrichia reveals their role in depleting sugar alcohols in the cecum. Microbiome. 2021;9:174.CrossRefPubMedPubMedCentral
11.
go back to reference Ahmed S, Busetti A, Fotiadou P, et al. In vitro characterization of gut microbiota-derived bacterial strains with neuroprotective properties. Front Cell Neurosci. 2019;13:402.CrossRefPubMedPubMedCentral Ahmed S, Busetti A, Fotiadou P, et al. In vitro characterization of gut microbiota-derived bacterial strains with neuroprotective properties. Front Cell Neurosci. 2019;13:402.CrossRefPubMedPubMedCentral
13.
go back to reference Yoshimura T. The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments. Cytokine. 2017;98:71–8.CrossRefPubMed Yoshimura T. The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments. Cytokine. 2017;98:71–8.CrossRefPubMed
14.
go back to reference Huang X, Wang X, Lu SM, et al. Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis. Int J Clin Exp Med. 2015;8:10274–83.PubMedPubMedCentral Huang X, Wang X, Lu SM, et al. Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis. Int J Clin Exp Med. 2015;8:10274–83.PubMedPubMedCentral
15.
go back to reference Lee E, Lee JW, Lee B, et al. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma. BMC Med Genomics. 2020;13:171.CrossRefPubMedPubMedCentral Lee E, Lee JW, Lee B, et al. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma. BMC Med Genomics. 2020;13:171.CrossRefPubMedPubMedCentral
17.
go back to reference Modarres P, Mohamadi Farsani F, Nekouie AA, Vallian S. Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML. Sci Rep. 2021;11:12485.CrossRefPubMedPubMedCentral Modarres P, Mohamadi Farsani F, Nekouie AA, Vallian S. Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML. Sci Rep. 2021;11:12485.CrossRefPubMedPubMedCentral
18.
go back to reference Chen G, Chen W, Ye M, Tan W, Jia B. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma. Biosci Rep. 2019;39:BSR20181277.CrossRefPubMedPubMedCentral Chen G, Chen W, Ye M, Tan W, Jia B. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma. Biosci Rep. 2019;39:BSR20181277.CrossRefPubMedPubMedCentral
19.
go back to reference Jo S, Im SH, Seo D, et al. Low-frequency repetitive magnetic stimulation suppresses neuroblastoma progression by downregulating the Wnt/β-catenin signaling pathway. Bioelectrochemistry. 2022;147:108205.CrossRefPubMed Jo S, Im SH, Seo D, et al. Low-frequency repetitive magnetic stimulation suppresses neuroblastoma progression by downregulating the Wnt/β-catenin signaling pathway. Bioelectrochemistry. 2022;147:108205.CrossRefPubMed
20.
go back to reference Lin L, Miao L, Lin H, et al. Targeting RAS in neuroblastoma: is it possible? Pharmacol Ther. 2022;236:108054.CrossRefPubMed Lin L, Miao L, Lin H, et al. Targeting RAS in neuroblastoma: is it possible? Pharmacol Ther. 2022;236:108054.CrossRefPubMed
Metadata
Title
Potential Cause-and-Effect Relationship between Gut Microbiota and Childhood Neuroblastoma: A Mendelian Randomization Analysis
Author
Jing Chu
Publication date
27-03-2024
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-024-05065-6